AU2008360004A1 - Particle compositions with a pre-selected cell internalization mode - Google Patents

Particle compositions with a pre-selected cell internalization mode Download PDF

Info

Publication number
AU2008360004A1
AU2008360004A1 AU2008360004A AU2008360004A AU2008360004A1 AU 2008360004 A1 AU2008360004 A1 AU 2008360004A1 AU 2008360004 A AU2008360004 A AU 2008360004A AU 2008360004 A AU2008360004 A AU 2008360004A AU 2008360004 A1 AU2008360004 A1 AU 2008360004A1
Authority
AU
Australia
Prior art keywords
particles
cell
particle
receptors
endocytosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008360004A
Other languages
English (en)
Inventor
Paolo Decuzzi
Mauro Ferrari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of AU2008360004A1 publication Critical patent/AU2008360004A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2008360004A 2008-07-29 2008-07-29 Particle compositions with a pre-selected cell internalization mode Abandoned AU2008360004A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/071470 WO2010014081A1 (fr) 2008-07-29 2008-07-29 Compositions de particules avec un mode d'internalisation de cellule présélectionné

Publications (1)

Publication Number Publication Date
AU2008360004A1 true AU2008360004A1 (en) 2010-02-04

Family

ID=40613085

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008360004A Abandoned AU2008360004A1 (en) 2008-07-29 2008-07-29 Particle compositions with a pre-selected cell internalization mode

Country Status (8)

Country Link
EP (1) EP2326314A1 (fr)
JP (1) JP2011529491A (fr)
KR (1) KR20110039466A (fr)
CN (1) CN102112117A (fr)
AU (1) AU2008360004A1 (fr)
CA (1) CA2732252A1 (fr)
MX (1) MX2011001121A (fr)
WO (1) WO2010014081A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170000875A1 (en) 2013-12-02 2017-01-05 Arytha Biosciences, Llc Toxoid preparation and uses thereof
US11110127B2 (en) 2014-06-02 2021-09-07 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders
US10434070B2 (en) 2015-01-02 2019-10-08 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to enable blood transfusion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009001461A (es) * 2006-08-08 2009-07-02 Univ Texas Suministro por etapas multiples de agentes activos.
US8563022B2 (en) * 2006-10-11 2013-10-22 Board Of Regents Of The University Of Texas System Particles for cell targeting

Also Published As

Publication number Publication date
WO2010014081A1 (fr) 2010-02-04
KR20110039466A (ko) 2011-04-18
JP2011529491A (ja) 2011-12-08
CA2732252A1 (fr) 2010-02-04
MX2011001121A (es) 2011-05-23
EP2326314A1 (fr) 2011-06-01
CN102112117A (zh) 2011-06-29

Similar Documents

Publication Publication Date Title
US20210338593A1 (en) Multistage delivery of active agents
US8563022B2 (en) Particles for cell targeting
US20120045396A1 (en) Porous structures with modified biodegradation kinetics
US8173115B2 (en) Particle compositions with a pre-selected cell internalization mode
US20110311452A1 (en) Inflammation targeting particles
US8361508B2 (en) Endocytotic particles
AU2008360004A1 (en) Particle compositions with a pre-selected cell internalization mode
WO2008041970A2 (fr) Procédés et compositions pour cibler un système vasculaire fenêtré
CN115645548A (zh) 一种装载药物的白蛋白-磁铁矿纳米颗粒给药系统及其制备方法
Jain et al. Nanopharmaceuticals
Ferrari et al. Multistage delivery of active agents
Jain et al. Nanopharmaceuticals
Patil et al. Nanopharmaceuticals for Drug Delivery

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period